Immunohistochemical staining further confirmed that MBZ-treated tumor cells exhibited significantly decreased or diminished expression of cell proliferation marker PCNA, which was shown highly expressed in the control group (Figure 7C). This evidence concerns the gene PCNA and neoplasm.